Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yavuz M Bilgin. (2021) Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update. Journal of Blood Medicine 12, pages 403-412.
Read now
Read now
Adebayo Ogunniyi, Mabel Rodriguez, Sean Devlin, Nelly Adel, Heather Landau, David J. Chung, Nikoletta Lendvai, Alexander Lesokhin, Guenther Koehne, Sham Mailankody, Neha Korde, Lilian Reich, Ola Landgren, Sergio Giralt & Hani Hassoun. (2017) Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency*. Leukemia & Lymphoma 58:5, pages 1123-1129.
Read now
Read now
Franziska Trautmann, Monica Cojoc, Ina Kurth, Nicolas Melin, Laure C. Bouchez, Anna Dubrovska & Claudia Peitzsch. (2014) CXCR4 as biomarker for radioresistant cancer stem cells. International Journal of Radiation Biology 90:8, pages 687-699.
Read now
Read now
Lloyd E Damon & Lauren E Damon. (2009) Mobilization of hematopoietic stem cells into the peripheral blood. Expert Review of Hematology 2:6, pages 717-733.
Read now
Read now
Miroslaw Janowski. (2009) Functional diversity of SDF-1 splicing variants. Cell Adhesion & Migration 3:3, pages 243-249.
Read now
Read now
Articles from other publishers (75)
Istemi Serin, Omur Gokmen Sevindik, Berrin Balik Aydin, Elif Melek, Yasa Gul Mutlu, Hulya Bilgen, Huseyin Bekoz & Leylagul Kaynar. (2023) Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?. Transfusion and Apheresis Science 62:6, pages 103809.
Crossref
Crossref
Amy P. Rossi, Simon Tremblay, Cyd M. Castro-Rojas, Ashley A. Burg, Krishna M. Roskin, Jenna M. Gehman, Adele Rike-Shields, Rita R. Alloway, Paul Brailey, David Allman, David A. Hildeman & E. Steve Woodle. (2023) Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates. American Journal of Transplantation 23:6, pages 759-775.
Crossref
Crossref
Anne Hubben, Danai Dima, Tahani Atieh, Chakra Chaulagain, Beth Faiman, Christina Ferraro, Sandra Mazzoni, Louis Williams, Christy Samaras, Jason Valent, Craig Sauter, Faiz Anwer & Jack Khouri. (2023) On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone. Bone Marrow Transplantation 58:5, pages 610-612.
Crossref
Crossref
Caterina Giovanna Valentini, Claudio Pellegrino, Rossana Putzulu, Matteo Bonanni, Giuseppina Massini, Nicoletta Orlando, Franca Forni, Maria Bianchi, Nicola Piccirillo & Luciana Teofili. (2023) Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor. Journal of Clinical Medicine 12:2, pages 618.
Crossref
Crossref
Basel T. Assaf, Claudia Harper & Jonathan A. Phillips. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
269
334
.
Simona Daniele, Simona Saporiti, Stefano Capaldi, Deborah Pietrobono, Lara Russo, Uliano Guerrini, Tommaso Laurenzi, Elham Ataie Kachoie, Luca Palazzolo, Vincenzo Russo, Maria Pia Abbracchio, Ivano Eberini & Maria Letizia Trincavelli. (2022) Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New Evidence. International Journal of Molecular Sciences 24:1, pages 261.
Crossref
Crossref
Ramin Madanchi, Nils W. Engel, Winfried Alsdorf, Christoph Oing, Christian Frenzel, Finn-Ole Paulsen, Carsten Bokemeyer & Christoph Seidel. (2022) Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients. Bone Marrow Transplantation 57:5, pages 729-733.
Crossref
Crossref
Hacer Gozde Gul, Mehmet Ali Erkurt, Ahmet Sarici, Irfan Kuku, Emin Kaya, Ilhami Berber, Mustafa Merter, Soykan Bicim & Mustafa Ozgul. (2021) An innovation in stem cell harvesting: Heparin use. Transfusion and Apheresis Science 60:5, pages 103240.
Crossref
Crossref
Xueliang Gao, Shenghui Qin, Yongxia Wu, Chen Chu, Baishan Jiang, Roger H. Johnson, Dong Kuang, Jie Zhang, Xi Wang, Anand Mehta, Kenneth D. Tew, Gustavo W. Leone, Xue-Zhong Yu & Haizhen Wang. (2021) Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. Journal of Clinical Investigation 131:16.
Crossref
Crossref
Junling Pang, Ya Luo, Dong Wei, Zhujie Cao, Xianmei Qi, Meiyue Song, Ying Liu, Zhaoguo Li, Jin Zhang, Baicun Li, Jingyu Chen, Jing Wang & Chen Wang. (2021) Comparative Transcriptome Analyses Reveal a Transcriptional Landscape of Human Silicosis Lungs and Provide Potential Strategies for Silicosis Treatment. Frontiers in Genetics 12.
Crossref
Crossref
Iwona Malinowska, Michal Romiszewski, Katarzyna Smalisz, Anna Stelmaszczyk - Emmel, Barbara Nasilowska - Adamska, Malgorzata Krol, Elzbieta Urbanowska, Agnieszka Brozyna & Bozenna Baginska - Dembowska. (2021) Plerixafor combined with G-CSF for stem cell mobilization in children qualified for autologous transplantation- single center experience. Transfusion and Apheresis Science 60:3, pages 103077.
Crossref
Crossref
M.A. Bekadja, B. Mansour, H. Ouldjeriouat, B. Entasoltan, S. Bouchama, L. Charef, K. Amani, N. Hakiki, F. Bouamama, S. Osmani, M. Brahimi, A. Arabi, R. Bouhass & N. Yafour. (2021) First experience of the use of a generic of plerixafor in peripheral blood stem cell mobilization in multiple myeloma and lymphoma patients. Transfusion and Apheresis Science 60:3, pages 103070.
Crossref
Crossref
Rong Zhang, Tingting Miao, Min Qin, Chengsi Zhao, Wei Wang, Chengcheng Zhang, Xinjian Liu, Ying Chen, Ailing Chen & Yong Wang. (2021) CX3CL1 Recruits NK Cells Into the Central Nervous System and Aggravates Brain Injury of Mice Caused by Angiostrongylus cantonensis Infection. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Sakthi Lenin, Elise Ponthier, Kaitlin G. Scheer, Erica C. F. Yeo, Melinda N. Tea, Lisa M. Ebert, Mariana Oksdath Mansilla, Santosh Poonnoose, Ulrich Baumgartner, Bryan W. Day, Rebecca J. Ormsby, Stuart M. Pitson & Guillermo A. Gomez. (2021) A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma. International Journal of Molecular Sciences 22:9, pages 4322.
Crossref
Crossref
Salonee Martins, Purva Salvi, Sai Tejaswi Lavuri, Manjita Srivastava, Shalini Sakthivel, Muneesh Kumar Barman, Kailash Chand, Meenakshi Singh, Subash C. Sonkar & Prudhvilal Bhukya. 2021. Handbook of Research on Advancements in Cancer Therapeutics. Handbook of Research on Advancements in Cancer Therapeutics
42
88
.
Maxwell S. DeNies, Alan V. Smrcka, Santiago Schnell & Allen P. Liu. (2020) β-arrestin mediates communication between plasma membrane and intracellular GPCRs to regulate signaling. Communications Biology 3:1.
Crossref
Crossref
Bruce Morland, Tomas Kepak, Sandro Dallorso, Julian Sevilla, Dermot Murphy, Roberto Luksch, Isaac Yaniv, Peter Bader, Jochen Rößler, Gianni Bisogno, Britta Maecker-Kolhoff, Peter Lang, C. Michel Zwaan, David Sumerauer, Gergely Kriván, John Bernard, Qianying Liu, Eileen Doyle & Franco Locatelli. (2020) Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC). Bone Marrow Transplantation 55:9, pages 1744-1753.
Crossref
Crossref
Lefan Zhuang, Pudpong Boriboonnangkul, Shirong Wang & Shan Yuan. (2020) Third time’s a charm? Mobilization of autologous peripheral blood stem cells in patients with two previous failed mobilizations with plerixafor. Transfusion 60:6, pages 1253-1259.
Crossref
Crossref
Caroline A. Anderson, Pallavi Patel, Jonathan M. Viney, Rhian M. Phillips, Roberto Solari & James E. Pease. (2020) A degradatory fate for CCR4 suggests a primary role in Th2 inflammation. Journal of Leukocyte Biology 107:3, pages 455-466.
Crossref
Crossref
Adeline N. Boettcher, Yunsheng Li, Amanda P. Ahrens, Matti Kiupel, Kristen A. Byrne, Crystal L. Loving, A. Giselle Cino-Ozuna, Jayne E. Wiarda, Malavika Adur, Blythe Schultz, Jack J. Swanson, Elizabeth M. Snella, Chak-Sum (Sam) Ho, Sara E. Charley, Zoe E. Kiefer, Joan E. Cunnick, Ellie J. Putz, Giuseppe Dell'Anna, Jackie Jens, Swanand Sathe, Frederick Goldman, Erik R. Westin, Jack C. M. Dekkers, Jason W. Ross & Christopher K. Tuggle. (2020) Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART−/−IL2RG−/Y SCID Pigs. Frontiers in Immunology 11.
Crossref
Crossref
Pavan Kumar Bhamidipati, Mark A. Fiala & John F. DiPersio. 2020. Best Practices of Apheresis in Hematopoietic Cell Transplantation. Best Practices of Apheresis in Hematopoietic Cell Transplantation
63
80
.
Cesar Homero Gutiérrez‐Aguirre, Dalila Marisol Alvarado‐Navarro, Alain Palomares‐Leal, Gerardo Mejía‐Jaramillo, Rosario Salazar‐Riojas, Andrés Gómez‐De León, Perla Rocío Colunga‐Pedraza, Guillermo Sotomayor‐Duque, José Carlos Jaime‐Pérez, Olga Graciela Cantú‐Rodríguez, Luz del Carmen Tarín‐Arzaga, Juan Antonio Flores‐Jiménez & David Gómez‐Almaguer. (2019) Reduced‐dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study. Transfusion 59:12, pages 3721-3726.
Crossref
Crossref
Carmen Murias Henriquez, Hendrik-Tobias Arkenau, Valérie Dutoit & Anna Patrikidou. 2019. Cancer Immunotherapy and Biological Cancer Treatments. Cancer Immunotherapy and Biological Cancer Treatments.
Asurayya Worrede, Olimpia Meucci & Alessandro Fatatis. (2019) Limiting tumor seeding as a therapeutic approach for metastatic disease. Pharmacology & Therapeutics 199, pages 117-128.
Crossref
Crossref
Fotios V. Michelis, David W. Hedley, Sonal Malhotra, Sue Chow, David Loach, Vikas Gupta, Dennis D. Kim, John Kuruvilla, Jeffrey H. Lipton, Auro Viswabandya & Hans A. Messner. (2019) Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability. Biology of Blood and Marrow Transplantation 25:6, pages 1158-1163.
Crossref
Crossref
Georgine E. de Greef, Eric Braakman, Bronno van der Holt, Jeroen J.W.M. Janssen, Eefke Petersen, Vladimir Vucinic, Nicole Thuss, Meriam Grootes & Jan J. Cornelissen. (2018) The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study. Transfusion 59:1, pages 316-324.
Crossref
Crossref
Hareth Nahi, Marina Celanovic, Qianying Liu, Johan Lund & Valdas Peceliunas. (2019) A Pilot, Exploratory, Randomized, Phase II Safety Study Evaluating Tumor Cell Mobilization and Apheresis Product Contamination in Patients Treated with Granulocyte Colony-Stimulating Factor Alone or Plus Plerixafor. Biology of Blood and Marrow Transplantation 25:1, pages 34-40.
Crossref
Crossref
Chen Qian, Asurayya Worrede-Mahdi, Fei Shen, Anthony DiNatale, Ramanpreet Kaur, Qiang Zhang, Massimo Cristofanilli, Olimpia Meucci & Alessandro Fatatis. (2018) Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy. Molecular Cancer Research 16:12, pages 1844-1854.
Crossref
Crossref
Sami Mamand, Rebecca L. Allchin, Matthew J. Ahearne & Simon D. Wagner. (2018) Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma. Scientific Reports 8:1.
Crossref
Crossref
Valerie I. Brown. 2018. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist
19
53
.
Szende Jakab, Erzsébet Lázár, István BenedekJrJr, Judit Beáta Köpeczi, Annamária Pakucs & István Benedek. (2017) New Treatment Methods in Multiple Myeloma. Journal of Interdisciplinary Medicine 2:2, pages 144-149.
Crossref
Crossref
Vincenzo Torraca, Claudia Tulotta, B. Ewa Snaar-Jagalska & Annemarie H. Meijer. (2017) The chemokine receptor CXCR4 promotes granuloma formation by sustaining a mycobacteria-induced angiogenesis programme. Scientific Reports 7:1.
Crossref
Crossref
Martin Stone, Jenni Hayward, Cheng Huang, Zil E. Huma & Julie Sanchez. (2017) Mechanisms of Regulation of the Chemokine-Receptor Network. International Journal of Molecular Sciences 18:2, pages 342.
Crossref
Crossref
Mélanie J. Domingues, Susan K. Nilsson & Benjamin Cao. (2016) New agents in HSC mobilization. International Journal of Hematology 105:2, pages 141-152.
Crossref
Crossref
N.F. Frydenlund & M. Mahalingam. 2017. Neurotrophins. Neurotrophins
497
531
.
M. Pizzi & G. Inghirami. 2017. Patient Derived Tumor Xenograft Models. Patient Derived Tumor Xenograft Models
305
339
.
Sharmilan Thanendrarajan & Tarun K. Garg. 2017. Imaging in Stem Cell Transplant and Cell-based Therapy. Imaging in Stem Cell Transplant and Cell-based Therapy
73
86
.
Julianty Angsana, Jiaxuan Chen, Liying Liu, Carolyn A. Haller & Elliot L. Chaikof. (2016) Efferocytosis as a regulator of macrophage chemokine receptor expression and polarization. European Journal of Immunology 46:7, pages 1592-1599.
Crossref
Crossref
Jagriti Pal, Vikas Patil, Baisakhi Mondal, Sudhanshu Shukla, Alangar S. Hegde, Arimappamagan Arivazhagan, Vani Santosh & Kumaravel Somasundaram. (2016) Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma. Genes & Cancer 7:3-4, pages 136-147.
Crossref
Crossref
Sun Hee Kim, Judith Thiesen & Irene Krämer. (2016) Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period. Pharmaceutical Technology in Hospital Pharmacy 1:2.
Crossref
Crossref
Pankita H. Pandya, Mary E. Murray, Karen E. Pollok & Jamie L. Renbarger. (2016) The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches. Journal of Immunology Research 2016, pages 1-13.
Crossref
Crossref
Yavuz M. Bilgin & Georgine E. de Greef. (2016) Plerixafor for stem cell mobilization. Current Opinion in Hematology 23:1, pages 67-71.
Crossref
Crossref
Karim Dorgham, Fabrice Cerini, Hubert Gaertner, Astrid Melotti, Irène Rossitto-Borlat, Guy Gorochov & Oliver Hartley. 2016. Chemokines. Chemokines
47
72
.
Axel Schulenburg, Katharina Blatt, Sabine Cerny-Reiterer, Irina Sadovnik, Harald Herrmann, Brigitte Marian, Thomas W Grunt, Christoph C Zielinski & Peter Valent. (2015) Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?. Journal of Hematology & Oncology 8:1.
Crossref
Crossref
Hanimi Reddy Bapatu, Ravi Kumar Maram & R. Satyanarayana Murthy. (2015) Robust and Rugged Stability-Indicating HPLC Method for the Determination of Plerixafor and Its Related Impurities in Drug Substances. Journal of Chromatographic Science 53:9, pages 1432-1442.
Crossref
Crossref
Hakan Goker, Sezgin Etgul & Yahya Buyukasik. (2015) Optimizing mobilization strategies in difficult-to-mobilize patients: The role of plerixafor. Transfusion and Apheresis Science 53:1, pages 23-29.
Crossref
Crossref
M.A. Bekadja, R. Bouhass, S. Osmani, M. Brahimi, S. Talhi, N. Yafour & A. Arabi. (2015) Plerixafor in the treatment of progenitor cell mobilization failure: First experience in Algeria. Hematology/Oncology and Stem Cell Therapy 8:2, pages 93-94.
Crossref
Crossref
Vijay K. Singh, Stephen Y. Wise, Oluseyi O. Fatanmi, Jessica Scott, Patricia L. P. Romaine, Victoria L. Newman, Amit Verma, Thomas B. Elliott & Thomas M. Seed. (2014) Progenitors Mobilized by Gamma-Tocotrienol as an Effective Radiation Countermeasure. PLoS ONE 9:11, pages e114078.
Crossref
Crossref
R E Clark, J Bell, J O Clark, B Braithwaite, U Vithanarachchi, N McGinnity, T Callaghan, S Francis & R Salim. (2014) Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients. Blood Cancer Journal 4:10, pages e255-e255.
Crossref
Crossref
Eric Chow, Kamakshi V. Rao, William A. Wood, Deborah Covington, Paul M. Armistead, James Coghill, Jonathan S. Serody, Don A. Gabriel, Katarzyna J. Jamieson, Yara A. Park, Jay S. Raval & Thomas C. Shea. (2014) Effectiveness of an Algorithm-Based Approach to the Utilization of Plerixafor in Patients Undergoing Chemotherapy-Based Stem Cell Mobilization. Biology of Blood and Marrow Transplantation 20:7, pages 1064-1068.
Crossref
Crossref
Vijay K Singh, Stephen Y Wise, Oluseyi O Fatanmi, Lindsay A Beattie & Thomas M Seed. (2014) Preclinical Development of a Bridging Therapy for Radiation Casualties. Health Physics 106:6, pages 689-698.
Crossref
Crossref
Tzu-Min Chan, Horng-Jyh Harn, Hui-Ping Lin, Pei-Wen Chou, Julia Yi-Ru Chen, Tsung-Jung Ho, Tzyy-Wen Chiou, Hong-Meng Chuang, Shao-Chih Chiu, Yen-Chung Chen, Ssu-Yin Yen, Mao-Hsuan Huang, Bing-Chiang Liang & Shinn-Zong Lin. (2014) Improved Human Mesenchymal Stem Cell Isolation. Cell Transplantation 23:4-5, pages 399-406.
Crossref
Crossref
Toby A. Eyre, Andrew J. King, Andrew Peniket, Vanderson Rocha, Graham P. Collins & Rachel Pawson. (2014) Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest. Transfusion 54:5, pages 1231-1234.
Crossref
Crossref
Vijay K. Singh, Stephen Y. Wise, Oluseyi O. Fatanmi, Lindsay A. Beattie, Elizabeth J. Ducey & Thomas M. Seed. (2014) Alpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation combined injury in mice. Journal of Radiation Research 55:1, pages 41-53.
Crossref
Crossref
A Sinclair, A L Latif & T L Holyoake. (2013) Targeting survival pathways in chronic myeloid leukaemia stem cells. British Journal of Pharmacology 169:8, pages 1693-1707.
Crossref
Crossref
François Kuonen, Chiara Secondini & Curzio Rüegg. (2012) Molecular Pathways: Emerging Pathways Mediating Growth, Invasion, and Metastasis of Tumors Progressing in an Irradiated Microenvironment. Clinical Cancer Research 18:19, pages 5196-5202.
Crossref
Crossref
Huanhuan Joyce Chen, Robert Edwards, Serena Tucci, Pengcheng Bu, Jeff Milsom, Sang Lee, Winfried Edelmann, Zeynep H. Gümüs, Xiling Shen & Steven Lipkin. (2012) Chemokine 25–induced signaling suppresses colon cancer invasion and metastasis. Journal of Clinical Investigation 122:9, pages 3184-3196.
Crossref
Crossref
Yusuke Shiozawa & Russell S. Taichman. (2012) Getting blood from bone: An emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche. Experimental Hematology 40:9, pages 685-694.
Crossref
Crossref
Albert Zlotnik & Osamu Yoshie. (2012) The Chemokine Superfamily Revisited. Immunity 36:5, pages 705-716.
Crossref
Crossref
Jochen Grassinger, Brenda Williams, Gemma H. Olsen, David N. Haylock & Susan K. Nilsson. (2012) Granulocyte colony stimulating factor expands hematopoietic stem cells within the central but not endosteal bone marrow region. Cytokine 58:2, pages 218-225.
Crossref
Crossref
Shinya Oishi & Nobutaka Fujii. (2012) Peptide and peptidomimetic ligands for CXC chemokine receptor 4 (CXCR4). Organic & Biomolecular Chemistry 10:30, pages 5720.
Crossref
Crossref
Jason A. Wojcechowskyj, Jessica Y. Lee, Steven H. Seeholzer & Robert W. Doms. (2011) Quantitative Phosphoproteomics of CXCL12 (SDF-1) Signaling. PLoS ONE 6:9, pages e24918.
Crossref
Crossref
Russell N. Wesson & Andrew M. Cameron. (2011) Stem Cells in Acute Liver Failure. Advances in Surgery 45:1, pages 117-130.
Crossref
Crossref
K. E. Herbert, J.-P. Levesque, A. K. Mills, D. J. Gottlieb, J. Cooney, J. Szer, J. Rasko & L. B. To. (2011) How we mobilize haemopoietic stem cells. Internal Medicine Journal 41:8, pages 588-594.
Crossref
Crossref
Vijay K. Singh, Pankaj K. Singh, Stephen Y. Wise & Thomas M. Seed. (2011) Mobilized progenitor cells as a bridging therapy for radiation casualties: A brief review of tocopherol succinate-based approaches. International Immunopharmacology 11:7, pages 842-847.
Crossref
Crossref
Menka SharmaFarhat AfrinNeeraj SatijaRajendra P. TripathiGurudutta U. Gangenahalli. (2011)
Stromal-Derived Factor-1/
CXCR4
Signaling: Indispensable Role in Homing and Engraftment of Hematopoietic Stem Cells in Bone Marrow
. Stem Cells and Development 20:6, pages 933-946.
Crossref
Crossref
H Atkins. (2010) Hematopoietic SCT for the treatment of multiple sclerosis. Bone Marrow Transplantation 45:12, pages 1671-1681.
Crossref
Crossref
Erik De Clercq. (2010) Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers. Pharmacology & Therapeutics 128:3, pages 509-518.
Crossref
Crossref
Anthony L. Mark, Zhaoli Sun, Daniel S. Warren, Bonnie E. Lonze, Matthew K. Knabel, George M. Melville Williams, Jayme E. Locke, Robert A. Montgomery & Andrew M. Cameron. (2010) Stem Cell Mobilization Is Life Saving in an Animal Model of Acute Liver Failure. Annals of Surgery 252:4, pages 591-596.
Crossref
Crossref
Myriam N Bouchlaka, Doug Redelman & William J Murphy. (2010) Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects. Immunotherapy 2:3, pages 399-418.
Crossref
Crossref
Hye-Yoon Choi, Chul-Soon Yong & Bong Kyu Yoo. (2010) Plerixafor for Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma. Annals of Pharmacotherapy 44:1, pages 117-126.
Crossref
Crossref
Shridhar Hegde & Michelle Schmidt. 2010.
466
537
.
Lindsey Tilling, Philip Chowienczyk & Brian Clapp. (2009) Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells. British Journal of Clinical Pharmacology 68:4, pages 484-492.
Crossref
Crossref
Aleksandra Pivkova, Sonja Genadieva-Stavrik, Zlate Stojanoski, Lidija Cevreska, Oliver Karanfilski, Sanja Trajkova, Svetlana Krstevska Balkanov, Vlado Milenkov & Borche Georgievski. (2009) Mobilization Strategies for Autologous Collection and Cryopreservation of Peripheral Blood Stem Cells in Patients with Lymphoproliferative Diseases. Macedonian Journal of Medical Sciences 2:3, pages 209-216.
Crossref
Crossref
Michael P. Rettig, Pablo Ramirez, Bruno Nervi & John F. DiPersio. 2009. Chemokines, Part A. Chemokines, Part A
57
90
.